NasdaqGS - Delayed Quote USD

Solid Biosciences Inc. (SLDB)

2.7600
-0.0100
(-0.36%)
At close: May 9 at 4:00:01 PM EDT
2.8500
+0.09
+(3.26%)
After hours: May 9 at 7:36:13 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
8,094
13,620
Operating Expense
129,728
129,728
104,315
107,368
85,874
Operating Income
-129,728
-129,728
-104,315
-99,274
-72,254
Net Non Operating Interest Income Expense
9,129
9,129
7,142
2,616
64
Other Income Expense
-4,098
-4,098
1,158
10,677
2
Pretax Income
-124,697
-124,697
-96,015
-85,981
-72,188
Net Income Common Stockholders
-124,697
-124,697
-96,015
-85,981
-72,188
Diluted NI Available to Com Stockholders
-124,697
-124,697
-96,015
-85,981
-72,188
Basic EPS
-3.06
--
-4.83
-10.10
-10.14
Diluted EPS
-3.06
--
-4.83
-10.10
-10.14
Basic Average Shares
40,816.6940
--
19,884.0070
8,512.0890
7,118.0240
Diluted Average Shares
40,816.6940
--
19,884.0070
8,512.0890
7,118.0240
Total Operating Income as Reported
-129,728
-129,728
-104,252
-106,452
-72,254
Total Expenses
129,728
129,728
104,315
107,368
85,874
Net Income from Continuing & Discontinued Operation
-124,697
-124,697
-96,015
-85,981
-72,188
Normalized Income
-119,947
-119,947
-96,078
-97,039
-72,188
Interest Income
9,469
9,469
7,582
2,616
64
Interest Expense
340
340
440
--
--
Net Interest Income
9,129
9,129
7,142
2,616
64
EBIT
-124,357
-124,357
-95,575
-99,274
-72,254
EBITDA
-121,902
-121,902
-92,994
-96,866
-69,290
Reconciled Depreciation
2,455
2,455
2,581
2,408
2,964
Net Income from Continuing Operation Net Minority Interest
-124,697
-124,697
-96,015
-85,981
-72,188
Total Unusual Items Excluding Goodwill
-4,750
-4,750
63
11,058
0
Total Unusual Items
-4,750
-4,750
63
11,058
0
Normalized EBITDA
-117,152
-117,152
-93,057
-107,924
-69,290
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/26/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LXEO Lexeo Therapeutics, Inc.
2.6900
-10.33%
 
RGNX REGENXBIO Inc.
7.52
+5.17%
 
QURE uniQure N.V.
12.79
+4.41%
 
DYN Dyne Therapeutics, Inc.
11.41
+1.02%
 
CAPR Capricor Therapeutics, Inc.
6.34
-9.04%
 
LRMR Larimar Therapeutics, Inc.
2.1200
-5.36%
 
WVE Wave Life Sciences Ltd.
6.59
+0.69%
 
MGTX MeiraGTx Holdings plc
5.42
-0.91%
 
CYTK Cytokinetics, Incorporated
31.70
-2.42%
 
KROS Keros Therapeutics, Inc.
13.65
-2.64%